IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 113 filers reported holding IGM BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 4.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,061 | -98.6% | 11,145 | -97.7% | 0.00% | -100.0% |
| Q2 2023 | $6,664,271 | 0.0% | 485,027 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,664,271 | -19.2% | 485,027 | +0.1% | 0.00% | -25.0% |
| Q4 2022 | $8,244,730 | -99.9% | 484,699 | -7.6% | 0.00% | -42.9% |
| Q3 2022 | $11,922,833,000 | +23.3% | 524,311 | -2.3% | 0.01% | +40.0% |
| Q2 2022 | $9,671,454,000 | -35.5% | 536,409 | -4.3% | 0.01% | -16.7% |
| Q1 2022 | $14,987,805,000 | +41.7% | 560,711 | +55.5% | 0.01% | +50.0% |
| Q4 2021 | $10,578,716,000 | -49.1% | 360,679 | +14.2% | 0.00% | -55.6% |
| Q3 2021 | $20,777,991,000 | -25.6% | 315,967 | -5.8% | 0.01% | -25.0% |
| Q2 2021 | $27,920,173,000 | +44.5% | 335,579 | +33.2% | 0.01% | +33.3% |
| Q1 2021 | $19,320,665,000 | -26.8% | 251,932 | -15.7% | 0.01% | -25.0% |
| Q4 2020 | $26,394,295,000 | +238.6% | 298,950 | +183.0% | 0.01% | +200.0% |
| Q3 2020 | $7,795,738,000 | +34.6% | 105,619 | +33.1% | 0.00% | 0.0% |
| Q2 2020 | $5,791,236,000 | – | 79,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |